These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26775206)

  • 1. Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol.
    Luo Y; Ji X; Liu J; Li Z; Wang W; Chen W; Wang J; Liu Q; Zhang X
    Bioelectrochemistry; 2016 Jun; 109():31-40. PubMed ID: 26775206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 27 T ultra-high static magnetic field changes orientation and morphology of mitotic spindles in human cells.
    Zhang L; Hou Y; Li Z; Ji X; Wang Z; Wang H; Tian X; Yu F; Yang Z; Pi L; Mitchison TJ; Lu Q; Zhang X
    Elife; 2017 Feb; 6():. PubMed ID: 28244368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
    Derry WB; Wilson L; Jordan MA
    Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyfoline induces mitotic catastrophe and apoptosis in cancer cells.
    Wu YC; Yen WY; Ho HY; Su TL; Yih LH
    Int J Cancer; 2010 Feb; 126(4):1017-28. PubMed ID: 19697325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J; O'brate A; Zelnak A; Giannakakou P
    Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
    Klaassen U; Wilke H; Seeber S
    J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural product Celastrol destabilizes tubulin heterodimer and facilitates mitotic cell death triggered by microtubule-targeting anti-cancer drugs.
    Jo H; Loison F; Hattori H; Silberstein LE; Yu H; Luo HR
    PLoS One; 2010 Apr; 5(4):e10318. PubMed ID: 20428237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
    Chen JG; Horwitz SB
    Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
    Chen JG; Yang CP; Cammer M; Horwitz SB
    Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells.
    Johnson KR; Wang L; Miller MC; Willingham MC; Fan W
    Clin Cancer Res; 1997 Oct; 3(10):1739-45. PubMed ID: 9815558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Anticancer Res; 2007; 27(5B):3535-9. PubMed ID: 17972514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel.
    Gellrich D; Becker S; Strieth S
    Cancer Lett; 2014 Feb; 343(1):107-14. PubMed ID: 24075957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry.
    Chang WL; Yu CC; Chen CS; Guh JH
    Biochem Pharmacol; 2015 Mar; 94(1):12-21. PubMed ID: 25615907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
    Kelling J; Sullivan K; Wilson L; Jordan MA
    Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
    Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
    Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.